首页> Acta ophthalmologica> Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections

Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections

导出原文传递

翻译打印收藏纠错

第一作者： Rasmussen, Annette

作者： Rasmussen, Annette ^[1] ; Sander, Birgit ; Larsen, Michael ; Brandi, Sara ; Fuchs, Josefine ; Hansen, Louise H. ; Lund-Andersen, Henrik

作者单位： Rigshosp Glostrup, Dept Ophthalmol, Nordre Ringvej 57, DK-2600 Glostrup, Denmark ^[1]

关键词 aflibercept clinical practice neovascular age-related macular degeneration ranibizumab visual acuity

发布时间 2017-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Acta ophthalmologica

2017年95卷2期

128-132页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Acta ophthalmologica

2017年95卷2期

128-132页

检索历史清除

Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections

Acta ophthalmologica

相似文献

同项目论文

Acta ophthalmologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections

Acta ophthalmologica

相似文献

同项目论文

Acta ophthalmologica

相关期刊

检索历史清除